Woodford Investment Management
Provides equity investment for venture and growth finance, R&D and working capital, and invests in several other patient capital vehicles which invest in scaleups.
Woodford manages the Woodford Equity Income Fund and the Woodford Patient Capital Fund; between them, they provide equity investment for venture and growth finance, R&D and working capital. The Equity Income Fund is limited to up to ten per cent in unquoted securities and the Patient Capital Fund is limited up to 80 per cent.
Beauhurst research indicates that Woodford’s funds typically invest between £2m-£40m, with the average size of deals being £32.7m. The funds invest in several other patient capital vehicles which invest in scaleups, including Draper Esprit and IP Group.
The funds have provided follow-on investments for 16 of the 32 companies it has backed since 2011. Of the 54 investments, 34 have been to companies based outside of London. It has contributed to nine deals into scaleups since 2011, worth £266m.
The firm has offices in Oxford and Exeter and invests mostly in UK businesses. The company vision is to provide patient capital to support young businesses “through to commercialisation and fulfillment of their long-term potential.” The firms says that it aims to invest in businesses “with the potential to become the FTSE 350 companies of the future.”
If you know any national or local scaleup programmes that you want to recommend as a potential case study for the Institute to consider please do get in touch: firstname.lastname@example.org